Select Equity Group L.P. Acquires 486,241 Shares of The Cooper Companies, Inc. $COO

Key Points

• Select Equity Group L.P. increased its stake in The Cooper Companies by 185.0%, now owning approximately 0.37% of the company, valued at $63.2 million.
• The stock has received mixed analysts' ratings, with a consensus target price of $86.64, indicating a potential for modest growth despite variability in individual analyst price targets.
• Insider purchases have occurred, including a recent acquisition of 3,000 shares by COO Daniel G. Mcbride and 10,000 shares by CEO Albert G. White III, suggesting confidence in the company's future performance.

Select Equity Group L.P. boosted its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 185.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 749,050 shares of the medical device company's stock after acquiring an additional 486,241 shares during the period. Select Equity Group L.P. owned 0.37% of Cooper Companies worth $63,182,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. raised its holdings in Cooper Companies by 17.0% during the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company's stock worth $399,340,000 after purchasing an additional 686,751 shares in the last quarter. Millennium Management LLC lifted its stake in Cooper Companies by 36.0% in the first quarter. Millennium Management LLC now owns 2,577,416 shares of the medical device company's stock valued at $217,405,000 after acquiring an additional 682,166 shares during the last quarter. Nuveen LLC bought a new stake in shares of Cooper Companies during the 1st quarter worth about $55,367,000. Findlay Park Partners LLP acquired a new position in Cooper Companies in the 1st quarter valued at $37,134,000. Finally, Price T Rowe Associates Inc. MD increased its position in Cooper Companies by 12.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,954,877 shares of the medical device company's stock worth $333,595,000 after buying an additional 425,400 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.9%

COO traded down $0.59 during trading on Wednesday, reaching $67.66. The company had a trading volume of 2,397,249 shares, compared to its average volume of 2,303,551. The company has a market cap of $13.45 billion, a P/E ratio of 33.33, a PEG ratio of 1.74 and a beta of 0.97. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $112.38. The business's fifty day moving average price is $71.85 and its 200 day moving average price is $76.37.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion during the quarter, compared to analysts' expectations of $1.06 billion. During the same period last year, the business earned $0.96 EPS. The business's quarterly revenue was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on COO shares. Mizuho decreased their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 16th. Loop Capital set a $100.00 price target on Cooper Companies in a research note on Tuesday, June 17th. Morgan Stanley set a $76.00 price target on Cooper Companies and gave the company an "equal weight" rating in a research report on Thursday, August 28th. Needham & Company LLC restated a "buy" rating and issued a $94.00 target price on shares of Cooper Companies in a research note on Thursday, August 28th. Finally, JPMorgan Chase & Co. cut their price target on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating for the company in a report on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Cooper Companies currently has an average rating of "Moderate Buy" and a consensus price target of $86.64.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III acquired 10,000 shares of the company's stock in a transaction that occurred on Friday, September 5th. The stock was acquired at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the acquisition, the chief executive officer directly owned 226,151 shares in the company, valued at $15,466,466.89. This represents a 4.63% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Gerard H. Warner III bought 1,450 shares of the business's stock in a transaction on Friday, September 5th. The shares were bought at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the completion of the acquisition, the chief operating officer directly owned 18,319 shares in the company, valued at approximately $1,268,224.37. This trade represents a 8.60% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 15,975 shares of company stock valued at $1,079,566 in the last three months. Corporate insiders own 1.98% of the company's stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.